论文部分内容阅读
AIM To compare survival and recurrence in hepatocellularcarcinoma （HCC） patients who did or did notreceive adjuvant transarterial chemoembolization（TACE）.METHODS： A consecutive sample of 229 patients whounderwent curative resection between March 2007and M